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“P<O.O1. 
Conclusions: AV sclerosis and albuminuria predict cardiovascular morbidity and mortal- 
Ity in hypertensive patients with electrocardiographic LV hypertrophy independently of 
each other and established cardiovascular nsk factors, indicating that they are not Inter- 
changeable markers of the same atherosclerotic process. 
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Background: The prevailing opinion in the medical literature is that mitral annular calcifi- 
cation (MAC) represents a manifestation of atherosclerosis and should alert the clinician 
to the possibility of cardiovascular disease. Despite the apparent link between MAC and 
atherosclerosis, there is limited data regarding the correlation between MAC and coro- 
nary (CHD) events in African Americans. The objective of this study is to assess if MAC 
predicts CHD events in the Jackson (completely African American) cohort of the ARIC 
Study. Methods: The study population included 2193 participants undergoing echo 
examinations between 1993 and 1996. Participants diagnosed with heart disease prior to 
visit 3 and participants who did not have adequate visualization of the mitral annulus to 
assess for MAC on 2D imaging were excluded. The primary outcome was incident CHD 
event [defined as hospitalized myocardial infarction (Ml), ECG (silent) MI, fatal coronary 
event or cardiac procedure] in ARIC as observed up to 1999. MAC was considered a 
binary variable (yes/no) and was adjusted for signlflcant confounders including gender, 
age, BMI, hypertension. diabetes, smoking status, renal function based on serum creati- 
nine, and total cholesterol to HDL ratio. Cox proportional hazard model was used for the 
analysis. Results: The prevalence of MAC was 4.6% for women and 5.6% for men. The 
prevalence increased with age. In participants aged 65 years and higher, the prevalence 
of MAC was 7.1% in women and 6.2% in men. During the 5 year follow up, there were 
122 total incident CHD events recorded, 62 of which were hospitalized Ml and fatal CHD 
events. The relatwe risk of hospitalized MI and fatal CHD events was 2.2 (95% Cl, 1.2 to 
4.1) for those with MAC. Aner adjustment, the risk for CHD events among the MAC sub- 
group was 2.4 (95% Cl, 1 .I to 5.0). Broadening the definition of CHD events to include 
procedures and silent MI the unadjusted relative risk was 2.2 (95% Cl,l.2 to 4.1) and 
adjusted relative risk was 2.0(95% Cl,l.O4 to 3.9) Conclusions: Despite the low preva- 
lence of MAC in this relatively young population of middle-aged African Americans, the 
presence of MAC incurs a significant risk for cardiovascular events. 
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Background: Severe degrees of mitral regurgitation (MR) are known to exert an unfavor- 
able prognosis. However, little is known regarding prognosis in patients with milder 
degrees of MR, particularly in patients with preserved systolic function. 
Methods: We quantitated MR by routine color flow Doppler echocardiography and evalu- 
ated its independent effect on mortality in 13.466 patients (41% male) with normal sys- 
tolic function (EF >/= 50%) followed for an average of 3.1 years. We then assessed the 
additional independent effect of pulmonary hypertension on prognosis in MR in a subset 
of patients where PAS was obtalned (n=7,776) 
Results: (See table; ‘pcO.0001 compared to none and mild, ~p<O.OOOl compared to all 
other groups, $p<O.O5 compared to none and mild). 
Conclusions: In patients with normal systolic function. a moderate level of MR is assow 
ated with a high mortality when PAS >/= 40 mmHg, similar in magnitude to a severe level 
of MR. In these patients, consideration should be aiven to surgical intervention or other 
measures to reduce PAS pressure 
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Contractility Measurement and Comparison With 
Census-Expected Survival 
Jeffrev S. Borer, Edmund M. Herrold, Phyllis G. Supine, Clam A. Hochreiter. Richard 8. 
Devereux, Mary J. Roman, Paul D. Kkgfield, 0. Wayne Isom, Karl H. Krieger, Andrew 
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Background: In asymptomatic pts with aortic regurgitation (AR) who have nl left ventricu- 
lar ejection fraction (LVEF) at rest and have not undergone valve replacement (AVR), we 
showed that contractility (wall-stress[ESS]-adjusted change [A] in LVEF from rest to ever- 
cise [ex]) from combined echo and radlonuclide angiography, is the best objective or clin- 
ical predictor of subsequent development of heart failure, subnl LVEFrest or sudden 
death. 
Methods: To confirm its value, in 71 consecutive pts with AR who underwent AVR. we 
related immediate pre-AVRALVEFAESS, other echo and radionuclide angiographic rest 
and ex variables, and symptoms, to survwal during 12+5 yrs post-AVR, and compared 
survival to that expected from age- and gender-matched U.S. census data. EFrest was nl 
pre-AVR in 4Oi71 pts; 51/71 had pm-op symptoms. Pts were divided into 3 groups 
according to pre-specified contractility cut-points used in our earlier study of non-AVR 
pts. 
Results: ALVEF-AESS predicted survival (p=.Ol); neither symptom status, EFrest, EFex, 
AEF, nor echo LV systolic/diastolic dimensions added significant predictive value. Among 
prespecified terciles. pts with near nl contractility (ALVEF-AESS-11%) had av annual 
death risk (AAR) of 1.7 %/yr. indistinguishable from U.S. census data (NS) but better 
than other terciles (pc.04); pts with ALVEFAESS -12% to -17% (middle tercile) had 
AAR=3.5%/yr (pc.025 vs census); pts with poorest ALVEF-AESS e17%) had 
AAR=7.l%/yr (p-z.005 vs census). 
Conclusions: In parallel with earlier results in non-AVR pts, direct contractility measure- 
ment immediately pre-AVR @LVEF adjusted for AESS from non-invasive measures) 
best predicts post-AVR survival compared with other clinical and objective functional/ 
geometric descriptors. Comparison with U.S. census data suggests that, with current sur- 
gical methods, pts with well-preserved contractility, irrespective of symptoms, survive 
post-AVR as well as non-AR persons; in contrast, poor pre-op contractility compromises 
outcome despite nl LVEFrest and irrespectwe of symptoms. “Prophylactic” AVR in pts 
with nl LVEFrest, no symptoms and poordLVEF-AESS may prevent further contractility 
loss and greater post-AVR risk. 
1157-22 Aortic Regurgitation: Long-Term Survival in Patients 
With Different Degrees of Left Ventricular Function 
Undergoing Surgical Treatment 
Pablo Stutzbach, Stella Yala, Sol Garrido, Jose Abud, Eduardo Dulbecco, Alejandro 
Machain, HBctor Raffaelli, Roberto R. Favaloro, Favaloro Foundation, Buenos Aires, 
Argentina 
Background: Outcomes of surgical treatment for aortic regurgitation have been mostly 
reported during the 1960s. However, surgical techniques and treatment of aortic regurgi- 
tation improved smce then. Therefore, it is necessary to update the information and 
review ten ventricular function parameters in relation to greater mortality rates. Our aim 
was to analyze long-term survival and prognostic variables I” patients undergoing sur- 
gery for aortic regurgitation in the past IO years. 
Methods: From August, 1992 to December, 2001, 450 pattents underwent surgery for 
severe aortic regurgitabon. Seventy-nine (16%) patients were excluded from the study, 
since they presented concomitant valvular heart or coronary diseases. Mean age was 
52*15 years; 74 (20%) were women, 67 (18%) were asymptomatic, 28 (7.5%) had his- 
tory of acute pulmonary edema (APE), and 166 (50.6%) had ~40% left ventricular ejec- 
tion fraction (LVEF). Mean left ventricular systolic diameter (LVSD) was 49+5mm. Kaplan 
Mew curves were used for survival analysis. Log-rank test was used for comparison of 
survival rates. Cox test was used for multivarlate analysis. 
Results: Total hospital mortality was 4% (15/371). Female sex (Pc.02) and LVEF ~40% 
(P=.OO2) were the variables associated to greater hospital mortality. Survival at 5 and 6 
years was 97.4*0.9% and 83.7t2.9% respectwely for the total population. Survival anal- 
ysis showed significant differences when comparing ~40% versus 40% LVEF (95% Cl, 
67.96% versus 78% Cl, 61.73%, P=.OO4) and Z3Omm versus c60mm LVSD (89% Cl, 
92.84% versus 70% Cl, 75.67%, k.006). Multivariate analysis of the variables associ- 
ated to mortality showed: age (P=.OO4). ~40% LVEF (F10.006). 260”” LVSD (f=.O74), 
and APE (E.01). 
Conclusion: Patients with isolated aortic regurgitation have low hospital mortality and 
excellent long-time survival despite LVEF impairment. 
